Genmab A/SGMABNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+515.5%
5Y CAGR+206.3%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+515.5%/yr
vs -59.8%/yr prior
5Y CAGR
+206.3%/yr
Recent acceleration
Acceleration
+575.2pp
Accelerating
Percentile
P97
Near historical high
vs 5Y Ago
269.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 546.28% |
| Q3 2025 | -82.84% |
| Q2 2025 | 3.17% |
| Q1 2025 | -7.82% |
| Q4 2024 | 16.26% |
| Q3 2024 | 3.08% |
| Q2 2024 | -4.09% |
| Q1 2024 | 2.81% |
| Q4 2023 | 1.60% |
| Q3 2023 | 8.09% |
| Q2 2023 | 6.05% |
| Q1 2023 | -0.54% |
| Q4 2022 | 2.34% |
| Q3 2022 | 9.25% |
| Q2 2022 | 8.14% |
| Q1 2022 | 1.85% |
| Q4 2021 | 4.26% |
| Q3 2021 | 5.09% |
| Q2 2021 | 0.80% |
| Q1 2021 | 6.27% |
| Q4 2020 | 2.03% |
| Q3 2020 | 3.27% |
| Q2 2020 | 744.40% |
| Q1 2020 | -84.97% |
| Q4 2019 | 10.74% |
| Q3 2019 | 45.16% |
| Q2 2019 | 1.01% |
| Q1 2019 | 2.18% |
| Q4 2018 | 14.16% |
| Q3 2018 | 1.78% |
| Q2 2018 | 5.13% |
| Q1 2018 | 3.97% |
| Q4 2017 | 18.51% |
| Q3 2017 | -3.12% |
| Q2 2017 | 6.48% |
| Q1 2017 | 4.54% |
| Q4 2016 | 22.47% |
| Q3 2016 | 4.37% |
| Q2 2016 | 8.25% |
| Q1 2016 | -4.49% |